Results from a sub-analysis of the Phase 2 RESONATE-17 (PCYC-1117) study showed IMBRUVICA® (ibrutinib) was associated with robust efficacy and a positive risk-benefit profile in patients with...

Gigamon Inc® (NYSE:GIMO), the leader in traffic visibility solutions, today announced that its management team will participate in the Raymond James Technology Investors Conference on Tuesday,...

Researchers from Caris Life Sciences® and Fox Chase Cancer Center – Temple Health announced the presentation of two studies revealing the potential for exploring new therapeutic options for...

Trade Informatics, a quantitative research and analytics firm specializing in transaction cost analysis (TCA) and automated trade execution services, recently spoke at the CQAsia Quantitative...

Middle- and high-school students from across the region are invited to attend the third annual Youth for the Environment and Sustainability, or YES, Conference on Saturday, January 30, 2016 in...